Generics in Mexico - Market Summary, Competitive Analysis and Forecast to 2025
Summary
Generics in Mexico industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Mexican generics market had total revenues of $6.2bn in 2020, representing a compound annual growth rate (CAGR) of 7% between 2016 and 2020.
- Market consumption volume increased with a CAGR of 1.2% between 2016 and 2020, to reach a total of 92.7% in 2020.
- A growing middle class and better access to health care services are greatly increasing consumer demand for pharmaceutical products, including generics, in Mexico.
Scope- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Mexico
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Mexico
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Mexico generics market with five year forecasts by both value and volume
Reasons to Buy- What was the size of the Mexico generics market by value in 2020?
- What will be the size of the Mexico generics market in 2025?
- What factors are affecting the strength of competition in the Mexico generics market?
- How has the market performed over the last five years?
- What are the main segments that make up Mexico's generics market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Market volume
- 1.4. Market volume forecast
- 1.5. Geography segmentation
- 1.6. Market rivalry
- 1.7. Competitive Landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 3.2. Market volume
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 5.2. Market volume forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strengths/weaknesses of the leading players?
- 7.3. Has there been any significant recent M&A activity?
- 7.4. How has the COVID-19 pandemic impacted leading players?
- 8 Company Profiles
- 8.1. Pfizer Inc.
- 8.2. Sun Pharmaceutical Industries Ltd
- 8.3. Aurobindo Pharma Ltd
- 8.4. Teva Pharmaceutical Industries Limited
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
List of TablesTable 1: Mexico generics market value: $ million, 2016-20Table 2: Mexico generics market volume: %, 2016-20Table 3: Mexico generics market geography segmentation: $ million, 2020Table 4: Mexico generics market value forecast: $ million, 2020-25Table 5: Mexico generics market volume forecast: %, 2020-25Table 6: Pfizer Inc.: key factsTable 7: Pfizer Inc.: Annual Financial RatiosTable 8: Pfizer Inc.: Key EmployeesTable 9: Pfizer Inc.: Key Employees ContinuedTable 10: Sun Pharmaceutical Industries Ltd: key factsTable 11: Sun Pharmaceutical Industries Ltd: Annual Financial RatiosTable 12: Sun Pharmaceutical Industries Ltd: Key EmployeesTable 13: Aurobindo Pharma Ltd: key factsTable 14: Aurobindo Pharma Ltd: Annual Financial RatiosTable 15: Aurobindo Pharma Ltd: Key EmployeesTable 16: Teva Pharmaceutical Industries Limited: key factsTable 17: Teva Pharmaceutical Industries Limited: Annual Financial RatiosTable 18: Teva Pharmaceutical Industries Limited: Key EmployeesTable 19: Mexico size of population (million), 2016-20Table 20: Mexico gdp (constant 2005 prices, $ billion), 2016-20Table 21: Mexico gdp (current prices, $ billion), 2016-20Table 22: Mexico inflation, 2016-20Table 23: Mexico consumer price index (absolute), 2016-20Table 24: Mexico exchange rate, 2016-20List of FiguresFigure 1: Mexico generics market value: $ million, 2016-20Figure 2: Mexico generics market volume: %, 2016-20Figure 3: Mexico generics market geography segmentation: % share, by value, 2020Figure 4: Mexico generics market value forecast: $ million, 2020-25Figure 5: Mexico generics market volume forecast: %, 2020-25Figure 6: Forces driving competition in the generics market in Mexico, 2020Figure 7: Drivers of buyer power in the generics market in Mexico, 2020Figure 8: Drivers of supplier power in the generics market in Mexico, 2020Figure 9: Factors influencing the likelihood of new entrants in the generics market in Mexico, 2020Figure 10: Factors influencing the threat of substitutes in the generics market in Mexico, 2020Figure 11: Drivers of degree of rivalry in the generics market in Mexico, 2020